These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7835004)

  • 1. Clinical correlation of anticentromere antibodies.
    Zuber M; Gotzen R; Filler I
    Clin Rheumatol; 1994 Sep; 13(3):427-32. PubMed ID: 7835004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticentromere antibodies--clinical correlates.
    Wade JP; Sack B; Schur PH
    J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with anticentromere antibodies, clinical features, diagnoses and evolution.
    Vlachoyiannopoulos PG; Drosos AA; Wiik A; Moutsopoulos HM
    Br J Rheumatol; 1993 Apr; 32(4):297-301. PubMed ID: 8461923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
    Kallenberg CG; Pastoor GW; Wouda AA; The TH
    Ann Rheum Dis; 1982 Aug; 41(4):382-7. PubMed ID: 7051989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
    Weiner ES; Earnshaw WC; Senécal JL; Bordwell B; Johnson P; Rothfield NF
    Arthritis Rheum; 1988 Mar; 31(3):378-85. PubMed ID: 2833902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical correlation of anticentromere antibody in Thai patients.
    Pakunpanya K; Verasertniyom O; Vanichapuntu M; Pisitkun P; Totemchokchyakarn K; Nantiruj K; Janwityanujit S
    Clin Rheumatol; 2006 May; 25(3):325-8. PubMed ID: 16220222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticentromere antibodies in subjects with no apparent connective tissue disease.
    Lee SL; Tsay GJ; Tsai RT
    Ann Rheum Dis; 1993 Aug; 52(8):586-9. PubMed ID: 8215621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticentromere antibody--clinical associations. A study of 44 patients.
    Caramaschi P; Biasi D; Manzo T; Carletto A; Poli F; Bambara LM
    Rheumatol Int; 1995; 14(6):253-5. PubMed ID: 7597381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticentromere antibodies: clinical and biological significance.
    Fritzler MJ; Ayer LM
    J Rheumatol; 1982; 9(4):489-90. PubMed ID: 6982333
    [No Abstract]   [Full Text] [Related]  

  • 15. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD; Smith CD; Senecal JL; Rothfield N
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ; Kinsella TD
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scl 70 antibody--a specific marker of systemic sclerosis.
    Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
    Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticentromere antibody in localized scleroderma.
    Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody profile in progressive systemic sclerosis as markers for esophageal involvement.
    Gonzalez R; Storr M; Bloching H; Seige M; Ott R; Allescher HD
    J Clin Gastroenterol; 2001 Feb; 32(2):123-7. PubMed ID: 11205646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.